A nurse is caring for a 58-year-old male patient in the intensive care unit admitted following acute myocardial infarction with cardiogenic shock, who has a pulmonary artery catheter in place. The patient's hemodynamic parameters show: pulmonary artery pressure (PAP) 45/25 mmHg, pulmonary capillary wedge pressure (PCWP) 22 mmHg, cardiac output (CO) 3.2 L/min, and systemic vascular resistance (SVR) 1800 dynes/sec/cm⁵. What is the nurse's priority intervention?

Prioritization Rationale

The priority intervention is to administer inotropic agents to improve cardiac contractility. In cardiogenic shock following myocardial infarction, the fundamental defect is impaired myocardial contractility . The goal of therapy is to break the vicious cycle of low output, hypoperfusion, and worsening cardiac function. Inotropes such as dobutamine or milrinone directly enhance contractility, which will increase cardiac output, improve tissue perfusion, and secondarily allow the compensatory SVR to decrease as the sympathetic drive is reduced. This directly addresses the underlying pathophysiology of pump failure.

Analysis of Incorrect Options

Increasing intravenous fluid administration (Option 1) is contraindicated. The PCWP of 22 mmHg already indicates volume overload and pulmonary venous congestion. Administering more fluid would further increase the filling pressure without improving contractility, worsening pulmonary edema and respiratory failure. Vasopressor medications (Option 2), such as norepinephrine, would increase SVR and blood pressure but at the cost of increasing the workload of the already-failing left ventricle. While vasopressors may be necessary for refractory hypotension, they are not the first-line priority when the primary issue is contractile dysfunction and afterload is already elevated. Preparing for immediate cardioversion (Option 3) is not indicated as there is no evidence of a tachyarrhythmia in the presented data; the hemodynamic profile is consistent with sinus tachycardia as a compensatory mechanism, not a primary arrhythmic event.

Clinical Integration and Monitoring

Advanced hemodynamic monitoring, as provided by the pulmonary artery catheter, is a cornerstone of goal-directed therapy in cardiac surgery and critical care to differentiate shock states and guide management . In this case, it precisely identifies a cardiogenic rather than hypovolemic or distributive etiology. After initiating inotropic support, the nurse would monitor for an increase in CO, a decrease in SVR, and a gradual reduction in PCWP as forward flow improves. For patients with refractory shock despite pharmacological support, mechanical circulatory support devices like veno-arterial ECMO or an intra-aortic balloon pump (IABP) may be considered to unload the left ventricle and support systemic perfusion, though their impact on myocardial recovery remains an area of active investigation . The presence of a low cardiac output state in this context is a critical marker of disease severity, and its correction is the immediate clinical priority .

• Cardiogenic Shock — A life-threatening condition where the heart's pumping function fails, preventing adequate oxygen delivery to tissues. Myocardial infarction is a major cause.
• Pulmonary Capillary Wedge Pressure — Pressure measured through a pulmonary artery catheter, which indirectly reflects left atrial pressure. It is used to assess left ventricular preload and function.
• Inotropic Agent — Drugs that increase the contractile force of the heart muscle. Used to improve cardiac output in cardiogenic shock (e.g., dobutamine, milrinone).
• Systemic Vascular Resistance — Resistance of the systemic blood vessels. Along with cardiac output, it determines mean arterial pressure. When cardiac output decreases, SVR increases as a compensatory mechanism.
• Pulmonary Artery Catheter — A catheter inserted into the pulmonary artery to directly measure pressures in the heart and lungs, as well as cardiac output. It is used for precise monitoring of hemodynamic status in critically ill patients.